APLT•benzinga•
Applied Therapeutics To Present Full 12-Month Clinical Results From The INSPIRE Phase 3 Trial Of Govorestat In A Late-Breaking Abstract Selected For Oral Presentation At The Peripheral Nerve Society 2025 Annual Meeting, Being Held May 17-20, 2025 In Edinb
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 9, 2025 by benzinga